Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2024 Filed Jun 4, 2024 20:43 UTC |
MIGAUSKY GEORGE VDirector
|
GrantCommon Stock | 4,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004655 · primarydocument.xml · nonDerivative · entry 1 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:43 UTC |
Zachary JenniferDirector
|
GrantStock Options (Right to Buy) · Derivative | 24,454 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001562180-24-004656 · primarydocument.xml · derivative · entry 2 Zachary Jennifer · CIK 0001737231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,454 Underlying: Common Stock · 24,454 shares Expires 2034-05-31 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:43 UTC |
Zachary JenniferDirector
|
GrantCommon Stock | 4,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004656 · primarydocument.xml · nonDerivative · entry 1 Zachary Jennifer · CIK 0001737231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,296 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:42 UTC |
Glucksmann AlexandraDirector
|
GrantStock Options (Right to Buy) · Derivative | 24,454 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001562180-24-004653 · primarydocument.xml · derivative · entry 2 Glucksmann Alexandra · CIK 0001658390 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,454 Underlying: Common Stock · 24,454 shares Expires 2034-05-31 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:42 UTC |
Glucksmann AlexandraDirector
|
GrantCommon Stock | 4,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004653 · primarydocument.xml · nonDerivative · entry 1 Glucksmann Alexandra · CIK 0001658390 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:41 UTC |
Fox Allan M.Director
|
GrantStock Options (Right to Buy) · Derivative | 24,454 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001562180-24-004651 · primarydocument.xml · derivative · entry 6 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,454 Underlying: Common Stock · 24,454 shares Expires 2034-05-31 F3 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:41 UTC |
Fox Allan M.Director
|
GrantCommon Stock | 4,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004651 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:39 UTC |
STUMP DAVID CDirector
|
GrantStock Options (Right to Buy) · Derivative | 24,454 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001562180-24-004649 · primarydocument.xml · derivative · entry 2 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,454 Underlying: Common Stock · 24,454 shares Expires 2034-05-31 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:39 UTC |
STUMP DAVID CDirector
|
GrantCommon Stock | 4,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004649 · primarydocument.xml · nonDerivative · entry 1 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:42 UTC |
KARABELAS ARGERIS NDirector
|
GrantStock Options (Right to Buy) · Derivative | 24,454 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001562180-24-004654 · primarydocument.xml · derivative · entry 2 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,454 Underlying: Common Stock · 24,454 shares Expires 2034-05-31 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:42 UTC |
KARABELAS ARGERIS NDirector
|
GrantCommon Stock | 4,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004654 · primarydocument.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:40 UTC |
Tasse DanielDirector
|
GrantStock Options (Right to Buy) · Derivative | 24,454 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001562180-24-004650 · primarydocument.xml · derivative · entry 2 Tasse Daniel · CIK 0001502785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,454 Underlying: Common Stock · 24,454 shares Expires 2034-05-31 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:40 UTC |
Tasse DanielDirector
|
GrantCommon Stock | 4,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004650 · primarydocument.xml · nonDerivative · entry 1 Tasse Daniel · CIK 0001502785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 14, 2024 Filed May 16, 2024 21:06 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-004104 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,354 Underlying: Common Stock · 15,000 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, which expires on May 19, 2025, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| May 14, 2024 Filed May 16, 2024 21:06 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 15,000 | $15.81 | $237,222.00 |
DisclosureSEC source: 0001562180-24-004104 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,035 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.59 to $16.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 14, 2024 Filed May 16, 2024 21:06 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 15,000 | $3.76 | $56,400.00 |
DisclosureSEC source: 0001562180-24-004104 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 423,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 21:05 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-003452 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,354 Underlying: Common Stock · 15,000 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, which expires on May 19, 2025, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 21:05 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 15,000 | $18.19 | $272,871.00 |
DisclosureSEC source: 0001562180-24-003452 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,035 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.82 to $18.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 21:05 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 15,000 | $3.76 | $56,400.00 |
DisclosureSEC source: 0001562180-24-003452 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 423,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 17:20 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,041 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-002907 · primarydocument.xml · derivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,041 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 17:20 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionCommon Stock | 20,041 | $3.76 | $75,354.16 |
DisclosureSEC source: 0001562180-24-002907 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 21:03 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-002771 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,354 Underlying: Common Stock · 15,000 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, which expires on May 19, 2025, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 21:03 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 15,000 | $21.86 | $327,942.00 |
DisclosureSEC source: 0001562180-24-002771 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,035 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.60 to $22.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 21:03 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 15,000 | $3.76 | $56,400.00 |
DisclosureSEC source: 0001562180-24-002771 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 423,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:05 UTC |
PAKOLA STEVEChief Medical Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 12,878 | $0.00 Strike: $22.25 | $0.00 |
DisclosureSEC source: 0001562180-24-002430 · primarydocument.xml · derivative · entry 3 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,277 Underlying: Common Stock · 12,878 shares Expires 2033-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 44,155 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2024, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:05 UTC |
PAKOLA STEVEChief Medical Officer
|
SaleCommon Stock | 12,878 | $28.36 | $365,220.08 |
DisclosureSEC source: 0001562180-24-002430 · primarydocument.xml · nonDerivative · entry 2 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,192 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:05 UTC |
PAKOLA STEVEChief Medical Officer
|
Exercise / conversionCommon Stock | 12,878 | $22.25 | $286,535.50 |
DisclosureSEC source: 0001562180-24-002430 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 23:28 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-001395 · primarydocument.xml · derivative · entry 4 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,354 Underlying: Common Stock · 15,000 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 23:28 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 10,348 | $16.88 | $174,722.88 |
DisclosureSEC source: 0001562180-24-001395 · primarydocument.xml · nonDerivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,035 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $16.78 to $17.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 23:28 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 4,652 | $16.47 | $76,625.88 |
DisclosureSEC source: 0001562180-24-001395 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 418,383 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.78 to $16.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 23:28 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 15,000 | $3.76 | $56,400.00 |
DisclosureSEC source: 0001562180-24-001395 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 423,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:39 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-000544 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,354 Underlying: Common Stock · 45,000 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 45,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2015, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:39 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 45,000 | $15.18 | $682,992.00 |
DisclosureSEC source: 0001562180-24-000544 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,035 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.52 to $15.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:39 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 45,000 | $3.76 | $169,200.00 |
DisclosureSEC source: 0001562180-24-000544 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 453,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 21:23 UTC |
PAKOLA STEVEChief Medical Officer
|
SaleCommon Stock | 17,237 | $17.39 | $299,789.35 |
DisclosureSEC source: 0001562180-24-000252 · primarydocument.xml · nonDerivative · entry 3 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,192 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $17.05 to $17.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:23 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantStock Options (Right to buy) · Derivative | 50,875 | $0.00 Strike: $18.34 | $0.00 |
DisclosureSEC source: 0001562180-24-000252 · primarydocument.xml · derivative · entry 4 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,875 Underlying: Common Stock · 50,875 shares Expires 2034-01-02 F5 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:23 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantCommon Stock | 32,051 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000252 · primarydocument.xml · nonDerivative · entry 2 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,429 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:23 UTC |
PAKOLA STEVEChief Medical Officer
|
Tax withholdingCommon Stock | 10,385 | $17.95 | $186,410.75 |
DisclosureSEC source: 0001562180-24-000252 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,378 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 16:22 UTC |
Danos OlivierChief Scientific Officer
|
GrantStock Options (Right to buy) · Derivative | 61,050 | $0.00 Strike: $18.34 | $0.00 |
DisclosureSEC source: 0001562180-24-000249 · primarydocument.xml · derivative · entry 5 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,050 Underlying: Common Stock · 61,050 shares Expires 2034-01-02 F7 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 16:22 UTC |
Danos OlivierChief Scientific Officer
|
GrantCommon Stock | 38,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000249 · primarydocument.xml · nonDerivative · entry 4 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,853 F6 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 16:22 UTC |
Danos OlivierChief Scientific Officer
|
Tax withholdingCommon Stock | 8,410 | $17.95 | $150,959.50 |
DisclosureSEC source: 0001562180-24-000249 · primarydocument.xml · nonDerivative · entry 3 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,391 F5 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the Issuer's common stock on December 29, 2023. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:07 UTC |
Mills Kenneth T.Director · President and CEO
|
GrantStock Options (Right to buy) · Derivative | 305,250 | $0.00 Strike: $18.34 | $0.00 |
DisclosureSEC source: 0001562180-24-000223 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,250 Underlying: Common Stock · 305,250 shares Expires 2034-01-02 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:07 UTC |
Mills Kenneth T.Director · President and CEO
|
GrantCommon Stock | 64,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000223 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408,035 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:07 UTC |
Mills Kenneth T.Director · President and CEO
|
Tax withholdingCommon Stock | 11,357 | $17.95 | $203,858.15 |
DisclosureSEC source: 0001562180-24-000223 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,932 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 16:17 UTC |
Vasista VittalChief Financial Officer
|
GrantStock Options (Right to buy) · Derivative | 76,313 | $0.00 Strike: $18.34 | $0.00 |
DisclosureSEC source: 0001562180-24-000246 · primarydocument.xml · derivative · entry 3 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,313 Underlying: Common Stock · 76,313 shares Expires 2034-01-02 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 16:17 UTC |
Vasista VittalChief Financial Officer
|
GrantCommon Stock | 16,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000246 · primarydocument.xml · nonDerivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,493 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 16:17 UTC |
Vasista VittalChief Financial Officer
|
Tax withholdingCommon Stock | 4,534 | $17.95 | $81,385.30 |
DisclosureSEC source: 0001562180-24-000246 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,467 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:34 UTC |
Simpson CurranChief Oper. & Tech. Officer
|
GrantStock Options (Right to buy) · Derivative | 61,050 | $0.00 Strike: $18.34 | $0.00 |
DisclosureSEC source: 0001562180-24-000257 · primarydocument.xml · derivative · entry 3 Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,050 Underlying: Common Stock · 61,050 shares Expires 2034-01-02 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:34 UTC |
Simpson CurranChief Oper. & Tech. Officer
|
GrantCommon Stock | 38,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000257 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,327 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:34 UTC |
Simpson CurranChief Oper. & Tech. Officer
|
Tax withholdingCommon Stock | 8,120 | $17.95 | $145,754.00 |
DisclosureSEC source: 0001562180-24-000257 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,865 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.